Inceptionr LLC Takes $1.24 Million Position in Healthpeak Properties, Inc. (NYSE:DOC)

Inceptionr LLC bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 61,295 shares of the real estate investment trust’s stock, valued at approximately $1,242,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. raised its stake in Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after buying an additional 4,056,931 shares during the last quarter. Thrivent Financial for Lutherans purchased a new position in Healthpeak Properties during the third quarter valued at $1,880,000. Swedbank AB purchased a new position in Healthpeak Properties during the third quarter valued at $1,832,000. Pathstone Holdings LLC purchased a new position in Healthpeak Properties during the third quarter valued at $1,968,000. Finally, Associated Banc Corp purchased a new position in Healthpeak Properties during the third quarter valued at $10,559,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Shares of DOC opened at $20.11 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties, Inc. has a one year low of $16.66 and a one year high of $23.26. The firm has a market capitalization of $14.07 billion, a P/E ratio of 57.45, a PEG ratio of 2.17 and a beta of 1.15. The business has a fifty day moving average of $20.19 and a 200 day moving average of $21.31.

Healthpeak Properties Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were issued a $0.305 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.22 annualized dividend and a dividend yield of 6.07%. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s payout ratio is presently 348.57%.

Analyst Ratings Changes

A number of brokerages have issued reports on DOC. Wedbush lowered their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, February 14th. Scotiabank lowered their price objective on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday, February 28th. Wells Fargo & Company lowered their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a report on Wednesday, January 15th. Finally, Mizuho reduced their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Healthpeak Properties has a consensus rating of “Moderate Buy” and an average target price of $23.92.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.